Article Text

Download PDFPDF
Original article
Agenesis of corpus callosum and optic nerve hypoplasia due to mutations in SLC25A1 encoding the mitochondrial citrate transporter
  1. Simon Edvardson1,
  2. Vito Porcelli2,
  3. Chaim Jalas3,
  4. Devorah Soiferman1,
  5. Yuval Kellner4,
  6. Avraham Shaag1,
  7. Stanley H Korman1,
  8. Ciro Leonardo Pierri2,
  9. Pasquale Scarcia2,
  10. Nitay D Fraenkel5,
  11. Reeval Segel6,
  12. Abraham Schechter7,
  13. Ayala Frumkin1,
  14. Ophry Pines4,
  15. Ann Saada1,
  16. Luigi Palmieri2,8,
  17. Orly Elpeleg1
  1. 1Monique and Jacques Roboh Department of Genetic Research, Hadassah, Hebrew University Medical Center, Jerusalem, Israel
  2. 2Department of Biosciences, Biotechnology and Biopharmaceutics, Laboratory of Biochemistry and Molecular Biology, University of Bari Aldo Moro, Bari, Italy
  3. 3Bonei Olam, Center for Rare Jewish Genetic Disorders, Brooklyn, New York, USA
  4. 4Department of Microbiology and Molecular Genetics, IMRIC, Faculty of Medicine, Hebrew University, Jerusalem, Israel
  5. 5Department of Respiratory Rehabilitation, Alyn Hospital, Jerusalem, Israel
  6. 6Institute of Medical Genetics, Shaare-Zedek Medical Center, Jerusalem, Israel
  7. 7Meuhedet Health Services, Jerusalem, Israel
  8. 8CNR Institute of Biomembranes and Bioenergetics, Bari, Italy
  1. Correspondence to Professor Orly Elpeleg, Monique and Jacques Roboh Department of Genetic Research, Hadassah, Hebrew University Medical Center, Ein karem, Jerusalem 91120, Israel; elpeleg{at}, Professor Luigi Palmieri, Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari Aldo Moro, Bari 70125, Italy; luigi.palmieri{at}


Background Agenesis of corpus callosum has been associated with several defects of the mitochondrial respiratory chain and the citric acid cycle. We now report the results of the biochemical and molecular studies of a patient with severe neurodevelopmental disease manifesting by agenesis of corpus callosum and optic nerve hypoplasia.

Methods and results A mitochondrial disease was suspected in this patient based on the prominent excretion of 2-hydroxyglutaric acid and Krebs cycle intermediates in urine and the finding of increased reactive oxygen species content and decreased mitochondrial membrane potential in her fibroblasts. Whole exome sequencing disclosed compound heterozygosity for two pathogenic variants in the SLC25A1 gene, encoding the mitochondrial citrate transporter. These variants, G130D and R282H, segregated in the family and were extremely rare in controls. The mutated residues were highly conserved throughout evolution and in silico modeling investigations indicated that the mutations would have a deleterious effect on protein function, affecting either substrate binding to the transporter or its translocation mechanism. These predictions were validated by the observation that a yeast strain harbouring the mutations at equivalent positions in the orthologous protein exhibited a growth defect under stress conditions and by the loss of activity of citrate transport by the mutated proteins reconstituted into liposomes.

Conclusions We report for the first time a patient with a mitochondrial citrate carrier deficiency. Our data support a role for citric acid cycle defects in agenesis of corpus callosum as already reported in patients with aconitase or fumarate hydratase deficiency.

  • Molecular Genetics
  • Neurology

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.